Harvard Bioscience, Inc. (HBIO):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Harvard Bioscience, Inc. (HBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME58380D
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月24日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Harvard Bioscience, Inc. (Harvard Bioscience) is a developer, manufacturer and marketer of scientific instruments, systems, and lab consumables for life science research, drug discovery, and clinical and environmental testing applications. The company’s product range is organized into five product families: fluidics that include syringe pumps and peristaltic pumps; lab equipment and supplies such as pipettes, glove, and tissue culture products among others for molecular biology labs; molecular analysis products that include spectrophotometers, microplate readers and amino acid analyzers; cell analysis products such as electroporation, electrofusion, and cell electrophysiology products; and physiology products that include instruments and accessories for tissue, organ, and animal based lab research. The company caters to research scientists, pharmaceutical and biotechnology companies. It has operations in North America and Europe. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience, Inc. (HBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Harvard Bioscience, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Harvard Bioscience Completes Acquisition Of Assets Of Coulbourn Instruments 10
Partnerships 11
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Equity Offering 12
Harvard Apparatus Regenerative Technology Raises USD3.6 Million in Public Offering of Shares 12
Harvard Apparatus Regenerative Technology Raises USD6.1 Million in Public Offering of Series B Convertible Preferred Stock 14
Acquisition 16
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience, Inc. – Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 24
Financial Announcements 24
Jul 30, 2015: Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million 24
Apr 30, 2015: Harvard Bioscience Reports First Quarter 2015 Financial Results 25
Feb 26, 2015: Harvard Bioscience Fourth Quarter 2014 Non-GAAP EPS Increases 100% Versus Fourth Quarter 2013 on Record Quarterly Revenues of $30.4 Million 27
Corporate Communications 29
Apr 30, 2015: Harvard Bioscience Appoints James Green to the Board of Directors and Announces Retirement of Robert Dishman From the Board 29
Feb 18, 2015: Harvard Bioscience Appoints Ryan Atienza to Vice President of Sales at Its Denville Scientific Subsidiary 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Harvard Bioscience, Inc., Medical Equipment, Key Facts, 2014 1
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Deals By Market, 2010 to YTD 2016 8
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Harvard Bioscience Completes Acquisition Of Assets Of Coulbourn Instruments 10
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Harvard Apparatus Regenerative Technology Raises USD3.6 Million in Public Offering of Shares 12
Harvard Apparatus Regenerative Technology Raises USD6.1 Million in Public Offering of Series B Convertible Preferred Stock 14
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience, Inc., Key Competitors 19
Harvard Bioscience, Inc., Key Employees 20
Harvard Bioscience, Inc., Subsidiaries 21

List of Figures
Harvard Bioscience, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

★海外企業調査レポート[Harvard Bioscience, Inc. (HBIO):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TriLink BioTechnologies Inc:企業のM&A・提携動向(医療分野)
    Summary TriLink BioTechnologies Inc (TriLink) is a biotechnology company that provides services to researchers in the areas of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. The company offers products including oligonucleotides, nucleotides, custom chemistry, DNA sy …
  • Rapiscan Systems, Inc.:企業の戦略・SWOT・財務分析
    SummaryRapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Glanbia Nutritionals Inc:企業の戦略的SWOT分析
    Glanbia Nutritionals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Guardian Industries Corp.:企業の戦略・SWOT・財務分析
    Guardian Industries Corp. - Strategy, SWOT and Corporate Finance Report Summary Guardian Industries Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-s …
  • Lantmannen Unibake International:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lantmannen Unibake Internationa …
  • Chipmos Technologies (Bermuda) Ltd. (IMOS):企業の財務及び戦略的SWOT分析
    Summary Chipmos Technologies (Bermuda) Ltd. (Chipmos) is a technology solutions provider that offers semiconductor testing and packaging solutions. The company offers services such as assembly services, enabling technologies, eService, gold bumping services, and testing services. It caters to integr …
  • Stentys SA (STNT):企業財務及び戦略的SWOT分析
    Summary Stentys SA (Stentys) is a medical technology company that develops and offers solutions to cardiologists to treat patients with acute myocardial infarction and coronary disease. The company’s products include BMS and DES stents, and aspiration catheter stents. Stentys’s stent is designed wit …
  • IVRCL Limited:企業の戦略・SWOT・財務分析
    SummaryIVRCL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • TRIiS Inc. (4840):企業の財務及び戦略的SWOT分析
    Summary TRIiS Inc. (TRIiS) is a holding company that provides business consulting solutions. The company operates through two business units such as fashion brand business and construction consultant business. Its fashion brand business includes rebranding and concurrently diversifying sales channel …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Beactica AB(製薬・医療分野):企業M&A動向
    Summary Beactica AB (Beactica) is a biopharmaceutical company. The company develops novel therapeutics. It provides services such as fragment-based lead generation yields, high-resolution kinetic data of inhibitors, extended rate analysis, optimization of the kinetics of lead compounds, integrated d …
  • Fidia farmaceutici S.p.A.(製薬・医療分野):企業M&A動向
    Summary Fidia farmaceutici S.p.A. (Fidia) is a pharmaceutical company. It develops and commercializes products for orthopedics, grammatology, rheumatology, and tissue repair. The company’s product portfolio includes medicinal product such as aciclin, clodron, clodron 200, clofend, and plus connettiv …
  • Finisar Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Finisar Corporation Mergers and …
  • GridPoint, Inc.:電力:M&Aディール及び事業提携情報
    Summary GridPoint, Inc. (GridPoint), a subsidiary of Twenty First Century Utilities LLC, is a smart buildings technology company. It provides visibility into facility operations, and assists customers to automate and control sites, lower energy spend, and manage day-to-day operations. The company pr …
  • Mercy Health Muskegon:企業のM&A・提携動向(医療分野)
    Summary Mercy Health Muskegon (Mercy Health) is a healthcare service provider that provides acute care services. The hospital offers medical services such as bariatric surgery and weight management, cancer care, cardiovascular medicine, emergency and urgent care, general surgery, imaging, blood draw …
  • HDFC Bank Ltd:企業の戦略・SWOT・財務情報
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tractor Supply Company:企業の戦略・SWOT・財務分析
    SummaryTractor Supply Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆